Sergiy Zhukovskiy

Sergiy Zhukovskiy is the chairman of the board of Genfa Global, a company that holds a 10% stake in the Russian pharmaceutical importer MIK. Recently, he was in the news regarding supply issues of the cystic fibrosis medication 'Trilexa' in Russia, where he claimed that the company fulfilled its contractual obligations in the delivery of the drug, amidst allegations of supply disruptions affecting patients.